Novartis AG - Enterprise Tech Ecosystem Series

Novartis AG - Enterprise Tech Ecosystem Series



In 2018, Novartis launched Novartis Biome, a global network of digital health innovation labs, to foster and empower health-tech start-up companies leverage data and digital technologies to make advancements in the healthcare sector.

Launched in February 2020, Novartis Biome India is a digital innovation hub that boosts connection and interaction between Novartis and partners from across the digital ecosystem, from emerging startups and academia to the biggest players in the industry.

Novartis signed an MoU with T-Hub, one of Indias largest technology incubators, to provide support to health-tech, healthcare, and pharmaceutical start-ups to expand their businesses.

The report provides information and insights into Novartiss tech activities, including -
- Insights of its digital transformation strategies and accelerator programs & innovation centers
- Overview of technology initiatives covering partnerships, product launches and investments
- Insights on each technology initiative including technology theme, objective, and benefits
- Details of estimated ICT budgets and major ICT contracts

Scope

- Novartis has embarked upon its digital transformation strategy by leveraging advanced analytics and other emerging technologies. And it has invested in efforts to improve the way it uses data in drug discovery and development; to improve the ways it engages with patients, doctors, and other stakeholders; and to automate business processes.
- Novartis is focusing on unifying its large data sets by partnering with data analytics companies such as SHYFT Analytics and Cota Healthcare, enabling a transparent flow of data and insights across its commercial and clinical development teams.
- Novartis is harnessing the power of emerging technologies such as big data, machine learning (ML), virtual reality (VR), and telemedicine among others to transform the healthcare ecosystem and achieve better health outcomes.
- Novartis opened up an innovation lab, Novartis Biome, a global network of digital health innovation labs; and collaborated with T-Hub, an Indian technology incubator to support health-tech, healthcare, and pharmaceuticals start-ups; and also developed a start-up program techcare to provide opportunities for running pilot projects.

Reasons to Buy

- Gain insights into Novartiss tech operations.
- Gain insights into its tech strategies and innovation initiatives.
- Gain insights into its technology themes under focus.
- Gain insights into various product launches, partnerships and investment strategies.

Overview
Digital Transformation Strategy
Accelerators, Incubators, & Other Innovation Programs
Technology Focus
Technology Initiatives
Venture Arm
Investments
Partnership & Investment Network Map
ICT Budgets & Contracts
Key Executives
About GlobalData

Novartis AG - Enterprise Tech Ecosystem Series

Novartis AG - Enterprise Tech Ecosystem SeriesIn 2018, Novartis launched Novartis Biome, a global network of digital health innovation labs, to foster and empower health-tech start-up companies leverage data and

USD 1495 View Report

Respiratory Diseases Drugs Global Market Forecast To 2022 Including: Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations Covering: GlaxosmithKline Plc, AstraZeneca Plc, Merck & Co, Novartis AG, Johnson & Johnson

The respiratory diseases drugs market consists of sales of respiratory diseases drugs and related services by entities (organizations, sole traders and partnerships) that produce drugs to treat respiratory diseases such

USD 4000 View Report

Adecco Group AG - Strategy, SWOT and Corporate Finance Report

Adecco Group AG - Strategy, SWOT and Corporate Finance ReportAdecco Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Swiss Steel Holding AG - Strategy, SWOT and Corporate Finance Report

Swiss Steel Holding AG - Strategy, SWOT and Corporate Finance ReportSwiss Steel Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information.

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available